(2020)
Clofarabine, cytarabine, and mitoxantrone in refractory/relapsed acute myeloid leukemia: High response rates and effective bridge to allogeneic hematopoietic stem cell transplantation.
Cancer Med 9(10),
3371-3382.

Prof. Dr. Gianni Panagiotou
Microbiome Dynamics · Head +49 3641 532-1759 gianni.panagiotou@leibniz-hki.deCurriculum vitae
Main Research Areas
- Medical & Environmental Metagenomics: human, mice, marine, plants;
- Systems Biology: -omics integration, chemical-protein & protein-protein interaction networks;
- Synthetic Biology: genome-scale metabolic modelling, design of probiotics, discovery of postbiotics
Publications
(2020)
Gastric bypass surgery in a rat model alters the community structure and functional composition of the intestinal microbiota independently of weight loss.
Microbiome 8(1),
13.
(2020)
Predictable modulation of cancer treatment outcomes by the gut microbiota.
Microbiome 8(1),
28.
(2020)
Lipid metabolic signatures deviate in sepsis survivors compared to non-survivors.
Comput Struct Biotechnol J 18,
3678-3691.
(2020)
Gut microbiome fermentation determines the efficacy of exercise for diabetes prevention.
Cell Metab 31(1),
77-91.
(2020)
Proteome analysis of bronchoalveolar lavage fluids reveals host and fungal proteins highly expressed during invasive pulmonary aspergillosis in mice and humans.
Virulence 11(1),
1337-1351.
(2020)
A metagenome-wide association study of gut microbiome and visceral fat accumulation.
Comput Struct Biotechnol J 18,
2596-2609.
(2020)
Antibiotics create a shift from mutualism to competition in human gut communities with a longer-lasting impact on fungi than bacteria.
Microbiome 8(1),
133.
(2020)
Triple RNA-seq reveals synergy in a human virus-fungus co-infection model.
Cell Reports 33(7),
108389.
(2019)
A pollution gradient contributes to the taxonomic, functional, and resistome diversity of microbial communities in marine sediments.
Microbiome 7(1),
104.